Lag Time, Scope Of Securities Class Actions Grow

Law360, New York (May 19, 2010, 7:32 PM EDT) -- Companies outside the financial sector may have thought they escaped securities class actions after announcing disappointing earnings. But the reprieve may well have been temporary, with a growing number of securities class actions hitting the docket long after the end of their proposed class periods.

One recent example is a securities class action filed against pharmaceuticals giant Pfizer Inc. alleging it failed to tell investors it was illegally promoting off-label uses for the anti-inflammatory drug Bextra and three other drugs and offering kickbacks to doctors to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.